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Aim:  Cooling  the  pharynx  and  upper  oesophagus  would  be more  advantageous  for  rapid  induction  of  ther-
apeutic  hypothermia  since  the  carotid  arteries  run in their  vicinity.  The  aim  of  this  study  was  to  determineeceived in revised form 4 August 2014 the  effects  of pharyngeal  cooling  on brain  temperature  and  the  safety  and feasibility  for  patients  under
ccepted 6 September 2014 resuscitation.eywords:
ardiac arrest
rain ischaemia
herapeutic hypothermia
Methods:  Witnessed  non-traumatic  cardiac  arrest  patients  (n  =  108)  were  randomized  to  receive  standard
care with  (n =  53)  or without  pharyngeal  cooling  (n = 55).  In the emergency  room,  pharyngeal  cooling  was
initiated before  or shortly  after  return  of spontaneous  circulation  by perfusing  physiological  saline  (5 ◦C)
into  a pharyngeal  cuff  for 120  min.
 A Spanish translated version of the summary of this article appears as Appendix in the ﬁnal online version at http://dx.doi.org/10.1016/j.resuscitation.2014.09.014.
∗ Corresponding author.
E-mail addresses: yoshit@cc.okayama-u.ac.jp, yoshimasatakeda@gmail.com (Y. Takeda).
ttp://dx.doi.org/10.1016/j.resuscitation.2014.09.014
300-9572/© 2014 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
icenses/by-nc-nd/3.0/).
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Pharynx
Selective cooling
Intra-arrest cooling
Results:  There  was  a signiﬁcant  decrease  in tympanic  temperature  at 40 min  after  arrival  (P  =  0.02)
with  a maximum  difference  between  the  groups  at 120 min  (32.9  ± 1.2 ◦C, pharyngeal  cooling  group  vs.
34.1 ± 1.3 ◦C,  control  group;  P < 0.001).  The  return  of  spontaneous  circulation  (70%  vs. 65%,  P = 0.63)  and
rearrest  (38%  vs.  47%,  P = 0.45)  rates  were  not  signiﬁcantly  different  based  on  the initiation  of  pharyngeal
cooling.  No  post-treatment  mechanical  or cold-related  injury  was  observed  on the  pharyngeal  epithe-
lium  by  macroscopic  observation.  The  thrombocytopaenia  incidence  was  lower  in  the  pharyngeal  cooling
group  (P  =  0.001)  during  the  3-day  period  after  arrival.  The  cumulative  survival  rate at 1 month  was  not
signiﬁcantly  different  between  the two groups.
Conclusions:  Initiation  of pharyngeal  cooling  before  or  immediately  after  the  return  of  spontaneous  circu-
lation  is safe  and  feasible.  Pharyngeal  cooling  can  rapidly  decrease  tympanic  temperature  without  adverse
effects  on  circulation  or the pharyngeal  epithelium.
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. Introduction
Mild hypothermia is known to ameliorate poor neurologi-
al outcomes after resuscitation in humans,1,2 with clinical3 and
aboratory4 data suggesting that early achievement of hypothermia
s one of the most important factors for good neurological out-
omes. However, rapid intravenous infusion of cold ﬂuid, which
s considered the technique for the fastest induction of hypother-
ia, may  increase rearrest rates even after return of spontaneous
irculation (ROSC) initiation.5 Furthermore, nasal cooling, which is
sed for intra-arrest cooling, may  cause serious epistaxis and peri-
rbital emphysema.6 Therefore, a technique that can be initiated
efore or shortly after ROSC without adverse effects is needed.
The bilateral common carotid arteries run near the pharynx
nd upper oesophagus. Therefore, cooling the pharyngeal region
ecreases brain temperature by cooling the blood in the carotid
rtery.7 We  developed a pharyngeal cooling system in which cold
aline (5 ◦C) is perfused into a pharyngeal cuff. The pharyngeal cool-
ng can be initiated before or shortly after ROSC. In a cardiac arrest
nimal model, pharyngeal cooling was initiated simultaneously
ith chest compression without having adverse effects on ROSC
nd pharyngeal epithelium.7,8
The primary aim of the present study was to determine the
afety and feasibility of pharyngeal cooling in patients with non-
raumatic cardiac arrest; the effects of particular interest were
OSC success and rearrest rates. The second aim was  to identify
he complications associated with the use of pharyngeal cooling,
.g., mechanical damage or cold-related injury to the pharyngeal
pithelium. The third aim was to determine the effects of cooling
n the tympanic and core temperatures during the initial 2-h period
fter arrival at the hospital.
. Methods
.1. Study design
This study was a multicentre, randomized, controlled clini-
al trial performed in 19 emergency medical centres in Japan
etween June 2009 and October 2013. The protocol was deter-
ined by a scientiﬁc advisory committee, in which emergency
epartments from seven universities in the Chugoku–Shikoku
rea in Japan participated, and was approved by the institutional
eview board of each participating centre. This study is regis-
ered at http://www.umin.ac.jp/ctr/index.htm (UMIN000002224
nd UMIN000008506).
Originally, the present study was ﬁnancially supported by the
inistry of Health, Labour and Welfare of Japan and was intendedo determine the effect of pharyngeal cooling on tympanic tem-
erature. In July 2010, the institutional review board at Okayama
niversity Medical School recommended discontinuation of this
ork because of the apparent decrease in tympanic temperatureblished  by Elsevier  Ireland  Ltd. This is  an open  access  article  under  the  CC
BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).
in the pharyngeal cooling group. In December 2011, after approval
by the institutional review board, the research was  resumed to
examine the effect of pharyngeal cooling on survival with the same
protocol and was  supported by Daiken Medical Co. Although the
sample size (108 cases) was  much smaller than the size required to
evaluate survival (692 cases), the study was terminated owing to
the end of the planned experimental period.
Written, informed consent was  obtained before enrolment
when the family of the patient was present. However, if the family
of the patient could not be located, the need for written, informed
consent was waived, and consent was  obtained as soon as possible.
Randomization assignments were generated with block sizes of 4 in
a 1:1 allocation to groups receiving standard care with or without
pharyngeal cooling. The emergency physician in each participating
centre checked the eligibility of patients and, when a patient was
eligible, telephoned the allocation centre.
2.2. Patients
The eligibility criteria included the following: aged 16–89
years and witnessed cardiogenic cardiac arrest or witnessed non-
cardiogenic cardiac arrest with resuscitation by medical personnel,
including emergency services, within 15 min  after collapse. Both
in-hospital and out-of-hospital cardiac arrests were included. The
exclusion criteria included the following: traumatic cardiac arrest,
core body temperature <34 ◦C upon arrival at the emergency room,
or pharyngeal or oesophageal disorder.
2.3. Treatments
Patients were resuscitated according to the 2005 or 2010 Amer-
ican Heart Association (AHA) Guidelines, depending on the date
of admission. Immediately after arriving at the emergency room,
pharyngeal cooling was  initiated during chest compression or
immediately after ROSC, if ROSC was  achieved before arrival, and
continued for 2 h unless the tympanic temperature decreased to
<32 ◦C. Although it was  encouraged to initiate whole body cooling
following 2 h of pharyngeal cooling, the decision regarding timing
and the technique were up to each facility based on their current
standard care practice, i.e. infusion of cold ﬂuid, ice pack, body
surface cooling, or percutaneous cardiopulmonary support. Resus-
citation measures were continued for at least 30 min  after arrival
at the emergency room.
2.4. Pharyngeal cooling
The pharyngeal cooling system (Daiken Medical Co., Osaka,
Japan) was  composed of a disposable pharyngeal cooling cuff (size
#4 for 50–70 kg body weight) and circulator (Fig. 1). The cuff was
made of vinyl chloride, designed to ﬁt the upper oesophagus and
pharynx and inserted using a manoeuvre similar to that for a
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Fig. 1. Pharyngeal cooling cuff (left) and circulator (right). Physiological saline (5 ◦C) is initially supplied to the oesophageal cuff through the inﬂow tube, where temperature
is  continuously monitored, and subsequently ﬁlls the pharyngeal cuff before being discharged through bilateral outlets. The bilateral outlets are connected to an outﬂow
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rhythm of asystole (OR = 0.3, P = 0.01) as a signiﬁcant factor forube,  where pressure is continuously monitored. According to a pilot study, intra-cu
han  the pressure monitored at the outlet tube, respectively. The intra-cuff pressure
as  passed biological safety tests, and tolerates up to 200 cm H2O of intra-cuff pres
upraglottic airway device after securing the airway by tracheal
ntubation. Physiological saline cooled to 5 ◦C was  perfused into the
uff at a rate of 500 ml  min−1 and pressure of 50 cm H2O. Intra-cuff
ressure and perfusate temperature were continuously monitored
t the outlet and the inlet tubes, respectively; the information was
ransmitted to the circulator for automatic feedback. After the pha-
yngeal cooling cuff was removed, the epithelium of the middle
harynx was visually examined.
.5. Recordings
Bilateral tympanic temperatures were measured using ther-
istor thermometers (TM400, Covidien Japan, Tokyo) while the
xternal auditory canals were insulated with adhesive wrapping
aterial.9 Rectal or bladder temperature was recorded as core body
emperature. For the patients who survived for more than 24 h,
he incidence of adverse events following resuscitation (systemic
nﬂammatory response syndrome (SIRS), acute lung injury, bac-
eraemia, decrease in platelets (<50,000 mm−3), and coagulopathy
activated partial thromboplastin time >50 s or prothrombin time-
nternational normalized ratio >1.5) was recorded for 72 h. Survival
as determined at 1 month.
.6. Data management
Tympanic temperature was automatically recorded into a data
ogger for both groups. Each participating centre sent a datasheet
nd an electronic ﬁle containing tympanic temperature to a data
anagement centre where all changes in history were logged and
nspected by external parties (Data Inspection Committee).
.7. Statistical analysis
The summary values for numerical variables are expressed as
edian and interquartile range or as mean ± standard deviation,
hile those for categorical variables are reported as counts and fre-
uencies. Differences between the control and pharyngeal cooling
roups were analysed using the Mann–Whitney U test for contin-
ous variables and 2 analysis for categorical variables. Changes
n temperature were analysed by two-factor ANOVA followed
y Scheffe’s test for multiple comparisons. Adjusted odds ratios
ORs) for ROSC and rearrest were estimated using multiple logisticsures at the oesophageal and pharyngeal cuffs were 8 cm H2O and 6 cm H2O higher
 pharyngeal cuff was controlled at 50 cm H2O. The cuff is made from vinyl chloride,
regression analyses. Adjusted relative risks (RRs) for survival at 1
month were estimated using the Cox proportional-hazards model.
Of the covariates listed in Table 1, important covariables selected
using the stepwise method were put into the model. These statis-
tical analyses were performed using a general purpose statistical
software package, StatFlex Ver. 6.0 (Artech Co., Osaka, Japan). Two-
tailed tests were performed with  ˛ = 0.05.
3. Results
The total experimental period was  37 months. Of the 4435
patients that were brought to the emergency room for resuscita-
tion during that time, 818 patients met  the inclusion criteria (Fig. 2).
Owing to a shortage of human resources in the critical care depart-
ment, 705 patients were not enrolled, at the discretion of their
treating physician (n = 680) or for other, unknown reasons (n = 25).
With the 113 patients that were enrolled, randomization was  per-
formed for intention-to-treat analysis (n = 57, control group; n = 56,
pharyngeal cooling group). After randomization, 2 patients were
excluded from the control group owing to the absence of family
(n = 2), resulting in 55 patients for analysis. In the treatment group,
3 patients were excluded owing to low body temperature (<34.0 ◦C,
n = 1), non-witnessed cardiac arrest (n = 1), and absence of family
(n = 1), resulting in 53 patients for analysis.
The baseline characteristics of the two  groups are shown in
Table 1. The majority of the patients suffered out-of-hospital car-
diac arrest, except for one patient in the control group and two
patients in the treatment group (P = 0.54). The proportion of male
patients was signiﬁcantly lower in the pharyngeal cooling group
(47%) than in the control group (67%, P = 0.03). Time from collapse to
arrival of the emergency medical service was  signiﬁcantly shorter
in the control group (median 7 min; range, 4–10 min) than the pha-
ryngeal cooling group (9 min; range, 5–11 min; P = 0.02) (Table 1).
The ROSC success rate, rearrest rate, adrenaline (epinephrine) dose,
and number of DC shocks were comparable between the two
groups. Multiple logistic regression analysis identiﬁed an initialROSC failure and cardiogenic cardiac arrest as a signiﬁcant factor
for rearrest (OR = 3.6, P = 0.02). The initiation of pharyngeal cooling
did not have a signiﬁcant effect on ROSC failure (OR = 1.3, P = 0.58)
or rearrest (OR = 0.8, P = 0.60).
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Table 1
Baseline characteristics of the patients with non-traumatic cardiac arrest, compared between the control and pharyngeal cooling groups.
Control (n = 55) Treatment (n = 53) P value
Age (years) 72 (64–78) 72 (62–81) 0.64
Male  sex 37 (67) 25 (47) 0.03
Witnessed by: EMS  8 (15) 6 (11) 0.62
Others 47 (85) 47 (89) 0.62
Bystander CPR 29 (55) 29 (58) 0.74
Location of arrest: out of hospital 54 (98) 51 (96) 0.61
In  hospital 1 (2) 2 (4) 0.61
Initial  rhythm: VF or pulseless VT 16 (29) 13 (25) 0.59
PEA  25 (45) 19 (36) 0.31
Asystole 13 (24) 20 (38) 0.11
Unknown 1 (2) 1 (2) 0.98
Cause  of arrest: cardiogenic cardiac arrest 30 (56) 27 (52) 0.71
Number of deﬁbrillation attempts 0 (0–2) 0 (0–1) 0.24
Adrenaline dose (mg) 4(1–6.5) 3 (1–6) 0.39
Spontaneous circulation on arrival at emergency room 11 (20) 13 (25) 0.57
Achieved ROSC 36 (65) 37 (70) 0.63
Rearrest 17 (47) 13 (38) 0.45
Time  from collapse to EMS  arrival 7 (4–10) 9 (5–11) 0.02
Time  from collapse to emergency room arrival (min) 31 (23–38) 32 (25–38) 0.58
Time  from collapse to the ﬁrst ROSC 33 (21–39) 32 (17–42) 0.65
C rical variables are reported as frequencies.
E ar ﬁbrillation; VT, ventricular tachycardia; PEA, pulseless electrical activity; ROSC, return
o
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Table 2
Use of pharyngeal cooling and whole body cooling within each group (control and
pharyngeal cooling groups).
Cooling measures Control (n = 55) Treatment
(n = 53)
P valueontinuous variables are presented as medians and interquartile ranges, and catego
MS,  emergency medical service; CPR, cardiopulmonary resuscitation; VF, ventricul
f  spontaneous circulation.
.1. Pharyngeal cooling
Pharyngeal cooling was initiated at 12 min  (7–22 min) after
rrival at the emergency room and was continued for 80 min
30–120 min) (Table 2). Twenty-four patients (45%) underwent
haryngeal cooling during chest compression (intra-arrest cool-
ng), and 29 patients (55%) underwent pharyngeal cooling shortly
fter ROSC (median, 17 min; range, 10–24 min) (Supplemental data
). After pharyngeal cooling, no mechanical damage or cold injury
as observed on the pharyngeal epithelium by macroscopic obser-
ation.
ROSC, ret urn of spontaneo us circ ulat ion
Control 
113 
Card iac  arrest   443 5 
Eligible   818 
Pharyngeal c ooling  
2  3 
55 53 
36 Achieved  ROS C 
Treated with wh ole  
body cool ing 
56 57 
37 
(24) (26) 
Survived more  th an 30 
days 
19 17 
Enrolled 
Randomiz ed 
Analysed 
Excluded 
Randomized 
Fig. 2. Flow of participants from recruitment to analysis.
Pharyngeal cooling
Number of patients,
n
– 53 –
Onset time from
arrival at
emergency room,
min
– 12 (7–22) –
Infusion of cold ﬂuid
Number of patients,
n
7 5 0.61
Onset from arrival
at emergency
room, min
21 (5.5–23) 2 (0–6) 0.07
Body surface cooling using a water blanket and gel-coated pad
Number of patients 19 18 0.88
Onset time from
arrival to
emergency room,
min
110 (97–185) 83 (63–124) 0.15
Number of patients
who underwent
initiation of body
surface cooling
within 2 h after
arriving at the
emergency room,
n
9 11 0.57
Ice  pack
Number of patients 1 2 0.60
Onset time from
arrival at
emergency room,
min
290 70, 78 in each –
Percutaneous cardiopulmonary support
Number of patients 1 0 0.32
Onset time from
arrival to
emergency room,
min
67 –
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Fig. 3. (A) Changes in body temperature. (B) Changes in tympanic temperature.
Blue circles indicate the temperature in the pharyngeal cooling group. Red triangles
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Table 3
Complications during the ﬁrst 3 days in patients with non-traumatic cardiac arrest
who survived more than 24 h, compared between the control and pharyngeal cool-
ing  groups.
Control (n = 23) Treatment (n = 26) P value
SIRS (%) 13 (57) 8 (31) 0.07
ALI  (%) 4 (17) 4 (15) 0.85
Bacteraemia (%) 5 (22) 3 (12) 0.34
Thrombocytopaenia (%) 4 (17) 0 (0) 0.03ndicate the temperature in the control group. *P < 0.05 compared to the control
roup; **P < 0.01 compared to the control group.
.2. Changes in temperature
Body temperature started to decrease gradually (0.02 ◦C min−1)
t 30 min  after arrival at the emergency room (Fig. 3A). At 120 min
fter arrival, the decrease in body temperature was signiﬁcantly
ifferent between the two groups (35.3 ± 1.0 ◦C, control group vs.
4.5 ± 1.1 ◦C, pharyngeal cooling group; P = 0.02).
In contrast, the tympanic temperature dramatically decreased
y 0.6 ◦C (0.06 ◦C min−1) during the ﬁrst 10 min  after arrival at
he emergency room (Fig. 3B). However, it decreased only 0.06 ◦C
uring the next 10 min. The tympanic temperature was signiﬁ-
antly different between the groups (34.1 ± 1.1 ◦C, control group
s. 33.7 ± 1.4 ◦C, pharyngeal cooling group; P = 0.02) at 40 min  after
rrival and reached the maximum difference (34.1 ± 1.3 ◦C, con-
rol group vs. 32.9 ± 1.2 ◦C, pharyngeal cooling group; P < 0.001) at
20 min.
.3. Whole body cooling
Whole body cooling was performed according to each centre’s
riteria in 26 patients in the control group and 24 patients in the
haryngeal cooling group (Table 2). Intravenous infusion of cold
uid was initiated in seven patients in the control group at 21 min
5.5–23 min) after arrival at the emergency room and ﬁve patients
vs. control group, P = 0.61) in the pharyngeal cooling group at 2 min
0–6 min, P = 0.07) after arrival. However, changes in temperature
n the patients who did not receive an intravenous infusion of cold
uid were similar to those of the entire sample (Supplementary
ata 2).Coagulopathy (%) 9 (39) 4 (15) 0.06
SIRS, systemic inﬂammatory response syndrome; ALI, acute lung injury.
3.4. Adverse events
During the ﬁrst 3 days, the incidences of SIRS, acute lung injury,
bacteraemia, and coagulopathy tended to be lower in the pha-
ryngeal cooling group, and the incidence of thrombocytopaenia
was signiﬁcantly lower in the pharyngeal cooling group (P < 0.001)
(Table 3).
3.5. Prognosis
The cumulative survival rate during the 1-month period after
cardiac arrest was not signiﬁcantly different between the two
groups (RR = 0.79, 95% conﬁdence interval [CI] = 0.49–1.28, P = 0.34).
4. Discussion
In the present study, tympanic temperature was measured as
an indicator of brain temperature; changes in tympanic temper-
ature have been reported to be very similar to changes in brain
surface and core brain temperatures during pharyngeal cooling
in monkeys.8 The tympanic temperature decreased by 0.6 ◦C dur-
ing the ﬁrst 10 min  in the pharyngeal cooling group followed by
a decrease of only 0.06 ◦C in the next 10 min. The mechanism
for this marked change is uncertain; a possible explanation is an
increase in the number of patients who  successfully achieved ROSC
and/or recovered blood pressure, because during chest compres-
sion, arterial blood passes slowly through the cervical region and
could efﬁciently exchange heat with the pharyngeal cooling cuff. It
has been shown previously in monkeys that the fastest decrease
in brain temperature during pharyngeal cooling was in animals
with low blood pressure owing to unstable circulatory conditions
following ROSC.8
The severity of systemic inﬂammation is an important factor
for post cardiac arrest syndrome (PCAS),10 which inﬂuences sur-
vival following resuscitation. In the present study, the incidence
rates of SIRS (57%, control group vs. 31%, pharyngeal cooling group,
P = 0.07) and coagulopathy (39% vs. 15%, P = 0.06) tended to be lower
in the pharyngeal cooling group during the ﬁrst 3 days, while the
thrombocytopaenia incidence (17% vs. 0%, P = 0.03) was signiﬁ-
cantly lower in the pharyngeal cooling group. The brain is rich in
tissue thromboplastin,11 and the severity of coagulopathy is consid-
ered an indication of brain damage12; therefore, these favourable
results in the pharyngeal cooling group may  indicate attenuation
of brain damage.
One of the most important factors causing neuronal damage
during ischaemia is glutamate,13 which is released in the ﬁrst
few minutes after ischaemic onset4 and rapidly diminishes after
ROSC.4 Hypothermia stops the release of glutamate14; therefore,
intra-arrest hypothermia could attenuate glutamate-initiated neu-
ronal damage.4 A prospective observational study demonstrated
that the initiation of intra-arrest hypothermia (32–34 ◦C) using
percutaneous cardiopulmonary support to out-of-hospital cardiac
arrest patients signiﬁcantly improved neurological outcomes 1 and
6 months after the collapse.15
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No mechanical damage was observed on the pharyngeal epithe-
ium after treatment. This is likely owing to the guided insertion of
he cuff into the centre of the pharynx and oesophagus, resulting
n equal pressure exerted on the top of the pharyngeal cooling cuff,
hich is hollow for contact with the tracheal tube during insertion.
oreover, the insertion manoeuvre for the pharyngeal cooling cuff
s similar to that for insertion of a supraglottic airway device, with
hich emergency physicians are familiar and likely to insert in a
autious manner.
In addition, the pharyngeal epithelium did not show signs of
old-induced injury, which can be initiated by two different mech-
nisms. The ﬁrst is the formation of ice crystals in the extracellular
pace, and the other is progressive formation of chilblain by release
f inﬂammatory mediators at temperatures >0 ◦C.16 Chilblain is
sually observed at the ﬁngertips, where blood ﬂow is severely
imited in a cold environment. However, the formation of ice crys-
als is unlikely since the perfusate temperature was controlled at
◦C. It was also unlikely that the latter mechanism was induced
n the pharynx, where blood ﬂow is abundant. However, to avoid
he possibility of cold-induced damage, the duration of pharyngeal
ooling was limited to 2 h after onset.
Neuropathy of the pharynx could also occur with pharyngeal
ooling. There have been case reports of recurrent laryngeal nerve
alsy17 and hypoglossal nerve palsy18 occurring after the use of
upraglottic airway devices, which are similar in shape to a pharyn-
eal cooling cuff. To avoid these neuropathies, it is recommended
o inﬂate supraglottic airway devices to <60 cm H2O.19 Therefore,
n the present study, the intra-cuff pressure was controlled at 50 cm
2O.
This study has certain limitations. First, physicians were not
linded to the treatment assignment. Therefore, the treatment
roup may  have received more extensive treatment during resus-
itation. However, since the adrenaline dose and number of DC
hocks were similar in both groups, we believe that the physicians
rovided similar treatment regardless of the treatment assign-
ent. Second, although 818 patients met  the inclusion criteria, 705
atients were not enrolled, primarily owing to manpower limita-
ions in the critical care department. Because the randomization
as performed after the enrolment and exclusion after enrolment
as limited (two patients in the control group and three patients in
he treatment group), we believe that the limited enrolment does
ot affect the data quality. Third, initiation of whole body cooling
26 patients in the control group and 24 patients in the treatment
roup) was not controlled by the experimental protocol but deter-
ined by each participating centre. Therefore, longitudinal changes
n temperature represent the effects of both pharyngeal cooling
nd whole body cooling. However, the differences between the two
roups likely represent the effects of pharyngeal cooling, given that
hole body cooling was initiated at a similar rate in both groups
Table 2).
. Conclusions
In conclusion, it appears that the initiation of pharyngeal cooling
s safe and feasible before and shortly after ROSC in the emer-
ency room. Tympanic temperature signiﬁcantly decreased in a
hort period of time without damage to the pharyngeal epithelium
r effects on the ROSC success and rearrest rates.
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